Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 105.17M | $ 78.02M | 74.19% |
3/31/2025 | $ 130.01M | $ 78.04M | 60.03% |
12/31/2024 | $ 146.45M | $ 78.09M | 53.32% |
9/30/2024 | $ 178.16M | $ 78.2M | 43.89% |
6/30/2024 | $ 210.61M | $ 78.23M | 37.14% |
3/31/2024 | $ 112.18M | $ 58.27M | 51.95% |
12/31/2023 | $ 147.26M | $ 58.28M | 39.58% |
9/30/2023 | $ 173.29M | $ 58.29M | 33.63% |
6/30/2023 | $ 173.4M | $ 36.87M | 21.26% |
3/31/2023 | $ 124.41M | $ 36.93M | 29.69% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for X4 PHARMACEUTICALS INC is calculated as follows: Debt [ $ 30.97M ] / Assets [ $ 133.13M ]
(=) Debt to Assets [ 23.26% ]
Minimum
Jun 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |